• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Jill A. Macoska, PhD


  • Gharaee-Kermani M, Mehra R, Robinson DR, Wei JT, Macoska JA.Complex cellular composition of solitary fibrous tumor of the prostate.Am J Pathol. 2014 Mar;184(3):732-9.
  • Gharaee-Kermani M, Macoska JA.Promising molecular targets and biomarkers for male BPH and LUTS.Current Urology Reports. 2013 Dec;14(6):628-37.
  • Rodriguez-Nieves JA, Macoska JA.Prostatic fibrosis, lower urinary tract symptoms, and BPH.Nat Rev Urol. 2013 Jul 16.
  • Gharaee-Kermani M, Rodriguez-Nieves JA, Mehra R, Vezina CA, Sarma AV, Macoska JA.Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model.Prostate. 2013 Jul;73(10):1123-33.
  • Agarwal M, He C, Siddiqui J, Wei JT, Macoska JA.CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer.Prostate. 2013 May;73(6):573-81.
  • Chen W, Weng S, Zhang F, Allen S, Li X, Bao L, Lam RH, Macoska JA, Merajver SD, Fu J.Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies.ACS Nano. 2013 Jan 22;7(1):566-75.
  • Macoska J.Prostatic Fibrosis Is Associated With Lower Urinary Tract Symptoms.J Urol. 2012 Dec 19.
  • Gharaee-Kermani M, Kasina S, Moore BB, Thomas D, Mehra R, Macoska JA.CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.PLoS ONE. 2012;7(11):e49278.
  • Ma J, Gharaee-Kermani M, Kunju L, Hollingsworth JM, Adler J, Arruda EM, Macoska JA.Prostatic fibrosis is associated with lower urinary tract symptoms.J Urol. 2012 Oct;188(4):1375-81.
  • Kasina S, Macoska JA.The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.Mol Cell Endocrinol. 2012 Apr 4;351(2):249-63.
  • Sottnik JL, Zhang J, Macoska JA, Keller ET.The PCa Tumor Microenvironment.Cancer Microenviron. 2011 Dec;4(3):283-97.
  • Macoska JA.Chemokines and BPH/LUTS.Differentiation.;82(4-5):253-60. Review.
  • Ricke WA, Macoska JA, Cunha GR.Developmental, cellular and molecular biology of benign prostatic hyperplasia.Differentiation.;82(4-5):165-7.
  • Sethi S, Macoska J, Chen W, Sarkar FH.Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.Am J Transl Res. 2010;3(1):90-9.
  • McDowell KL, Begley LA, Mor-Vaknin N, Markovitz DM, Macoska JA.Leukocytic promotion of prostate cellular proliferation.Prostate. 2010 Mar 1;70(4):377-89.
  • Macoska JA, Adsule S, Tantivejkul K, Wang S, Pienta KJ, Lee CT.-(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro.Pharmacol Res.;58(5-6):323-31.
  • Cooper CR, Graves B, Pruitt F, Chaib H, Lynch JE, Cox AK, Sequeria L, van Golen KL, Evans A, Czymmek K, Bullard RS, Donald CD, Sol-Church K, Gendernalik JD, Weksler B, Farach-Carson MC, Macoska JA, Sikes RA, Pienta KJ.Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha.J Cell Biochem. 2008 Aug 15;104(6):2298-309.
  • Begley LA, Kasina S, Mehra R, Adsule S, Admon AJ, Lonigro RJ, Chinnaiyan AM, Macoska JA.CXCL5 promotes prostate cancer progression.Neoplasia. 2008 Mar;10(3):244-54.
  • Sarma AV, Burke JP, Jacobson DJ, McGree ME, St Sauver J, Girman CJ, Lieber MM, Herman W, Macoska J, Montie JE, Jacobsen SJ.Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.Diabetes Care. 2008 Mar;31(3):476-82.
  • Demichelis F, Greulich H, Macoska JA, Beroukhim R, Sellers WR, Garraway L, Rubin MA.SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines.Nucleic Acids Res. 2008 Apr;36(7):2446-56.
  • Macoska JA, Begley LA, Dunn RL, Siddiqui J, Wei JT, Sarma AV.Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA.Prostate. 2008 Mar 1;68(4):442-52.
  • Begley LA, MacDonald JW, Day ML, Macoska JA.CXCL12 activates a robust transcriptional response in human prostate epithelial cells.J Biol Chem. 2007 Sep 14;282(37):26767-74.
  • Macoska JA.Ancestry, genetic susceptibility, E-cadherin-160A and prostate cancer risk-is there an association?.J Urol. 2006 Aug;176(2):435-6.
  • Barrett JM, Rovedo MA, Tajuddin AM, Jilling T, Macoska JA, MacDonald J, Mangold KA, Kaul KL.Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII.Prostate. 2006 May 1;66(6):632-50.
  • Begley L, Monteleon C, Shah RB, Macdonald JW, Macoska JA.CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro.Aging Cell. 2005 Dec;4(6):291-8.